Changsha-headquartered pharmaceutical company Hunan Nucien Pharmaceutical Co., Ltd, is targeting an initial public offering (IPO) on China’s Nasdaq-like STAR Market to raise about 1.2 billion yuan ($175 million).
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
